Navigation Links
ThromboGenics NV Announces Business Update and Half Year Results 2009
Date:8/27/2009

,393 - 62,393 Net result 2009 (4,663) (4,663) (4,663) Conversion of warrants by 2,783 2,783 ThromboGenics Ltd Contribution in kind Thrombogenics Ltd shares 2,783 (2,783) Conversion of warrants by ThromboGenics NV 241 241 Exchange rate differences as a result of retranslation of foreign subsidiary 11 11 Share based payments 249 249 Fair-Value Adjustment Investments 72 72 Balance sheet at 30 Jun 2009 (48,622) 61,086 - 61,086

About ThromboGenics

ThromboGenics is a biotechnology company focused on the discovery and development of innovative medicines for the treatment of eye disease, vascular disease and cancer. The Company's lead product microplasmin is in Phase III clinical development for the non-surgical treatment of back of the eye diseases. Microplasmin is also being evaluated in Phase II clinical development for additional vitreoretinal indications and as a potential therapy for stroke. ThromboGenics is also developing novel antibody therapeutics in collaboration with BioInvent International; these include TB-402 (Anti-Factor VIII), a long acting anti-coagulant, and TB-403 (anti-PlGF) for cancer.

ThromboGenics has built strong links with the University of Leuven and the Flanders Institute for Biotechnology (VIB) and has exclusive rights to certain therapeutics developed at these institutions. ThromboGenics is headquartered in Leuven, Belgium. The Company is listed on Eurolist by Euronext Brussels unde
'/>"/>

SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ThromboGenics NV: Business Update
2. ThromboGenics Announces Business Update and 2008 Full Year Results
3. ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
4. ThromboGenics N.V.: Business Update
5. ThromboGenics Announces Half Year Results 2008
6. ThromboGenics Appoints Dr. Patrik De Haes as Chief Executive Officer
7. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
8. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
9. ThromboGenics N.V. - Business Update
10. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
11. ThromboGenics Announces 2007 Full Year Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...fficacy endpoint has been met for patients with ad..., QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/...) (the "Company"), a global biopharmaceutical comp...ay announced positive efficacy data from a Phase 2...te, AEZS-108 (formerly AN-152), in patients with a...
(Date:11/24/2009)...Nov. 24, 2009 Arena Phar...ay that the company is scheduled to present at the...on December 1, 2009 at 11:30 a.m. Eastern Time (8:... in New York City. Jack Lief, Arena,s President an... an overview of the company, including its clinica...
(Date:11/24/2009)...rogram Connects Customers with Partners Validated ...Genotek Products , Ottawa... leading provider of products for biological sampl... announced its new global partner program. The pro...ek,s partner community and is designed to help par...
(Date:11/23/2009)... 2009 In a provocative new study, a University of...emissions the major cause of global warming cann...ses or society builds the equivalent of one new nu...y that there will be any substantial near-term dep...on dioxide emission rates," says the new paper by ...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...eb. 11 Further to Phlo,Corporation,s ("Phlo"") (O... Affiliate Begins Roll Out to Metropolitan New Yor...ompany") announced today that the,Company,s distri...elivered,AQISS(TM) to the following initial retail...roll out. AQISS(TM) is currently available for sal...
... February 8, Michael F. Brigham,President and CEO ...www.immucell.com ),updated the investment communit...net . Topics covered in the interview include an o...pportunity and upcoming milestones for,which inves...entirety, visit http://www.wallst.net and,click ...
.... 11 Caliper Life,Sciences, Inc. (Nasdaq: CALP )...sche Bank 2008 Small and Mid Cap Growth Conference...February 13 at 4:40 p.m. EST. Kevin,Hrusovsky, Pre...date on the,company,s business. The live webcast c...ye/confLobby.zhtml?ticker=CALP&item_id=17485 ,73. ...
Other Biology Technology:Phlo Affiliate Reports Progress in New York City Metropolitan Area Roll-Out 2WallSt.net Updates Investment Community Through All-New Interview With ImmuCell 2
(Date:11/25/2009)...rs, police officers and ambulance workers faced a ... complex. They battled to save people from the col...ed fires and evacuated as many people as they coul...eople. And making their jobs even harder was the p...and their relatives jammed mobile networks with ca...
(Date:11/25/2009)...009 Soil is the linchpin of the environment, wher...pite that, many students see soil as "just dirt" ...ence educators are challenged with the task of hel...l importance of soil in the environment. , A co...nce teachers at University of Nebraska-Lincoln, Or...
(Date:11/25/2009)...ssistant professors recently received funding from... research beneficial to understanding the environm...her Blackwood, assistant professor in the Departme...upport two separate research projects. , His fir...ommunities and Functions from the Leaf to the Land...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2Kent State University professors focus research on the environment with grants totaling $890,000 2New STR Systems from Promega Comply with Latest DNA Database Standards 14313 1New STR Systems from Promega Comply with Latest DNA Database Standards 14313 2Smoking in Pregnancy Linked to Psychotic Symptoms in Kids 58637 1Smoking in Pregnancy Linked to Psychotic Symptoms in Kids 58637 2Clarian Health Selects Watch4net for Performance Reporting and Automatic Analysis 58635 1Clarian Health Selects Watch4net for Performance Reporting and Automatic Analysis 58635 2
...08 Children who have been diagnosed with Fetal Al...us psychiatric and behavioral problems later in li...hool, unemployment, and criminal behavior. Studie...ent in minimizing the negative effects of FAS. Un...ays possible, especially if certain physical chara...
...on on International Trade in Endangered Species (C...of wild sturgeon and their prized caviar eggs from...nce has analyzed the quotas, which are re-set each...s are virtually unchanged from 2007 and do little ...rgeon species are endangered, having been overfish...
...h down to having the right genetic mix as it is to...y. , Psychologists at the University of Edinburgh...for Medical Research in Australia found that happi...d that both personality and happiness are largely ...ts use to rate personalities, called the Five-Fact...
Other Biology News:CITES caviar export quotas remain steady for beluga sturgeon despite threat of extinction 2CITES caviar export quotas remain steady for beluga sturgeon despite threat of extinction 3
EGTA, Molecular Biology Grade from Research Organics, Inc.
EGTA, Molecular Biology Grade from Research Organics, Inc.
...and negatively supercoiled DNA in presence of EDTA...coiling on transcription in vitro , Studying chro...egree of supercoiling of naturally occurring DNA ...by only one base-pair , Increasing restriction en...
PARP Cleavage Immunoblotting Assay Kit from Upstate
Biology Products: